carfilzomib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

Grupo Cooperativo de Hemopatías Malignas (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmultiple myeloma

I am/have/hadanemia

I am/have/hadcell transplantation

I am/have/hadbone marrow plasma cells

I am/have/hadrenal failure

I am/have/hadautologous hematopoietic stem cell transplant

I am/have/hadbone lesion

I am/have/hadcalcium

I am/have/hadbone marrow procedure

added new label for I am/have/had

more

I am looking for

I am looking forcarfilzomib

I am looking forlenalidomide

I am looking fordexamethasone

I am looking fordaratumumab

I am looking forcalcium

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Carfilzomib Daratumumab Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Carfilzomib in combination with lenalidomide, daratumumab and dexamethasone (KRDd) can induce profound clinical responses. The investigators want to observe the effectiveness of the quadruple therapy of carfilzomib, lenalidomide, daratumumab and dexamethasone on patients receiving 8 cycles of KRDd with autologous stem cell transplantation versus patients with 8 cycles of KRDd …

daratumumab

renal failure

bone marrow procedure

bone marrow plasma cells

cell transplantation

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.